57 related articles for article (PubMed ID: 1720201)
1. High prevalence of circulating antibodies to MuLV p30 antigen in human sera. An autoimmune response?
Kovarík A; Hlubinová K; Prachar J; Simkovic D; Cebecauer L; Feldsamová A
Neoplasma; 1991; 38(5):475-82. PubMed ID: 1720201
[TBL] [Abstract][Full Text] [Related]
2. Immune response of the mouse to the major core protein (p30) of ecotropic leukemia viruses.
Nowinski RC; Watson A
J Immunol; 1976 Aug; 117(2):693-6. PubMed ID: 59785
[TBL] [Abstract][Full Text] [Related]
3. Presence of circulating antibodies against gag-gene MuLV proteins in patients with autoimmune connective tissue disorders.
Rucheton M; Graafland H; Fanton H; Ursule L; Ferrier P; Larsen CJ
Virology; 1985 Jul; 144(2):468-80. PubMed ID: 2998055
[TBL] [Abstract][Full Text] [Related]
4. Natural antibodies in human sera cross-reactive with type C RNA tumor viral P 30.
Herbrink P; van Bussel FJ; Warnaar SO
Anticancer Res; 1982; 2(5):291-6. PubMed ID: 6299171
[TBL] [Abstract][Full Text] [Related]
5. Detection of polymorphism in BALB/c leukemia viruses with mouse antisera.
Brown JP; Boiocchi M; Nowinski RC
J Virol; 1979 Oct; 32(1):345-9. PubMed ID: 94360
[TBL] [Abstract][Full Text] [Related]
6. Endogenous ecotropic murine leukemia viral (MuLV) envelope protein as a new autoantigen reactive with non-obese diabetic mice sera.
Choi SE; Kim KS; Kim KH; Choi UY; Kim HM; Yoon JW; Kang Y
J Autoimmun; 2000 Nov; 15(3):347-57. PubMed ID: 11040075
[TBL] [Abstract][Full Text] [Related]
7. Antibodies to murine leukemia virus gp70 and p15(E) in sera of BALB/c mice immunized with syngeneic chemically induced sarcomas.
Klitzman JM; Brown JP; Hellström KE; Hellström I
J Immunol; 1980 Jun; 124(6):2552-6. PubMed ID: 6246166
[TBL] [Abstract][Full Text] [Related]
8. Anomalous reactions of mouse alloantisera with cultured tumor cells. II. Cytotoxicity is caused by antibodies to leukemia viruses.
Nowinski RC; Klein PA
J Immunol; 1975 Nov; 115(5):1261-8. PubMed ID: 170342
[TBL] [Abstract][Full Text] [Related]
9. Sera from patients with multiple sclerosis react with human cell T lymphotropic virus-I gag proteins but not env proteins--Western blotting analysis.
Ohta M; Ohta K; Mori F; Nishitani H; Saida T
J Immunol; 1986 Dec; 137(11):3440-3. PubMed ID: 3023483
[TBL] [Abstract][Full Text] [Related]
10. p65 of Gazdar murine sarcoma viruses contains antigenic determinants from all four of the murine leukemia virus (MuLV) gag polypeptides (p15, p12, p30, and p10) and can be cleaved in vitro by the MuLV proteolytic activity.
Yoshinaka Y; Luftig RB
Virology; 1982 Apr; 118(2):380-8. PubMed ID: 6178211
[No Abstract] [Full Text] [Related]
11. Anti-52 kDa Ro(SSA) autoantibodies in different autoimmune diseases preferentially recognize epitopes on the central region of the antigen.
Dorner T; Feist E; Wagenmann A; Kato T; Yamamoto K; Nishioka K; Burmester GR; Hiepe F
J Rheumatol; 1996 Mar; 23(3):462-8. PubMed ID: 8832984
[TBL] [Abstract][Full Text] [Related]
12. C-terminal region of human T cell lymphotropic virus type I (HTLVI) p19 core protein is immunogenic in humans and contains an HTLVI-specific epitope.
Palker TJ; Scearce RM; Copeland TD; Oroszlan S; Haynes BF
J Immunol; 1986 Apr; 136(7):2393-7. PubMed ID: 2419433
[TBL] [Abstract][Full Text] [Related]
13. Detection and analysis of antibodies against retrovirus determinants in the sera of haematologic patients.
Etkin AF; Litvinov SV; Gurevich MM
Acta Virol; 1989 Mar; 33(2):151-61. PubMed ID: 2569811
[TBL] [Abstract][Full Text] [Related]
14. Cell surface antigens of chemically induced fibrosarcomas: detection by a monoclonal antibody of a tumor-restricted Mr 12,000 protein gag antigen encoded by a dual-tropic murine leukemia virus.
Carbone G; Pierotti MA; Boiocchi M; De Leo AB; Ballinari D; Radice P; Borrello MG; Meseguer A; Cernuschi A; Parmiani G
Cancer Res; 1985 Oct; 45(10):4980-5. PubMed ID: 2992769
[TBL] [Abstract][Full Text] [Related]
15. Detection of antibodies cross-reactive with type C RNA tumor viral p30 protein in human sera and exudate fluids.
Herbrink P; Moen JE; Brouwer J; Warnaar SO
Cancer Res; 1980 Jan; 40(1):166-73. PubMed ID: 6243087
[TBL] [Abstract][Full Text] [Related]
16. The specificity of H-2-restricted cytotoxic T lymphocytes directed to AKR/Gross leukemia virus-induced tumors. III. Coordinate alterations in viral gp70 antigen expression and restoration of CTL-susceptibility to insusceptible variant tumors.
Manjunath R; Graziano RF; Green WR
J Immunol; 1986 Mar; 136(6):2271-9. PubMed ID: 3005407
[TBL] [Abstract][Full Text] [Related]
17. Clinical manifestations in 100 Japanese bullous pemphigoid cases in relation to autoantigen profiles.
Tanaka M; Hashimoto T; Dykes PJ; Nishikawa T
Clin Exp Dermatol; 1996 Jan; 21(1):23-7. PubMed ID: 8689764
[TBL] [Abstract][Full Text] [Related]
18. Antibodies presumably cross-reacting with mouse retrovirus type B and C in the sera of both leukemia-lymphoma and mammary cancer patients.
Segal-Eiras A; Croce MV; Pasqualini CD
Arch Geschwulstforsch; 1983; 53(4):321-7. PubMed ID: 6312922
[TBL] [Abstract][Full Text] [Related]
19. Preparation of syngeneic tumor regressor serum reactive with the unique determinants of the Abelson murine leukemia virus-encoded P120 protein at the cell surface.
Witte ON; Rosenberg N; Baltimore D
J Virol; 1979 Sep; 31(3):776-84. PubMed ID: 92572
[TBL] [Abstract][Full Text] [Related]
20. Detection and biochemical characterization of antigens in human leukemic sera that cross-react with primate C-type viral proteins (Mr 30,000).
Hehlmann R; Schetters H; Erfle V; Leib-Mösch C
Cancer Res; 1983 Jan; 43(1):392-9. PubMed ID: 6291760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
